γ-H2AX in Cancer Cells: A Potential Biomarker for Cancer Diagnostics, Prediction and Recurrence
暂无分享,去创建一个
[1] S. Leachman,et al. Melanoma cells express elevated levels of phosphorylated histone H2AX foci. , 2005, The Journal of investigative dermatology.
[2] M. Serrano,et al. The power and the promise of oncogene-induced senescence markers , 2006, Nature Reviews Cancer.
[3] Kai Rothkamm,et al. Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[4] J. Lieberman,et al. A phosphatase complex that dephosphorylates γH2AX regulates DNA damage checkpoint recovery , 2006, Nature.
[5] Dimitris Kletsas,et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions , 2005, Nature.
[6] J. Barrett,et al. Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks , 2004, Nature Cell Biology.
[7] Thea D. Tlsty,et al. Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes , 2001, Nature.
[8] Joe Y. Chang. Telomerase: A potential molecular marker and therapeutic target for cancer , 2004, Journal of surgical oncology.
[9] D. Durocher,et al. γH2AX as a Checkpoint Maintenance Signal , 2006 .
[10] Gavin D. Grant,et al. Common markers of proliferation , 2006, Nature Reviews Cancer.
[11] C. Redon,et al. Involvement of H2AX in the DNA Damage and Repair Response , 2003 .
[12] M. Kastan,et al. Disappearance of the Telomere Dysfunction-Induced Stress Response in Fully Senescent Cells , 2004, Cancer Research.
[13] T. Ushijima,et al. Diagnostic and therapeutic applications of epigenetics. , 2005, Japanese journal of clinical oncology.
[14] E. Rogakou,et al. Megabase Chromatin Domains Involved in DNA Double-Strand Breaks in Vivo , 1999, The Journal of cell biology.
[15] R. Weichselbaum,et al. gamma-H2AX as a therapeutic target for improving the efficacy of radiation therapy. , 2006, Current cancer drug targets.
[16] S. Madhusudan,et al. The emerging role of DNA repair proteins as predictive, prognostic and therapeutic targets in cancer. , 2005, Cancer treatment reviews.
[17] F. Alt,et al. Histone H2AX A Dosage-Dependent Suppressor of Oncogenic Translocations and Tumors , 2003, Cell.
[18] P. Olive,et al. Radiation Sensitivity, H2AX Phosphorylation, and Kinetics of Repair of DNA Strand Breaks in Irradiated Cervical Cancer Cell Lines , 2004, Cancer Research.
[19] P. Olive,et al. Endogenous expression of phosphorylated histone H2AX in tumors in relation to DNA double-strand breaks and genomic instability. , 2006, DNA repair.
[20] K. Manova,et al. H2AX is required for chromatin remodeling and inactivation of sex chromosomes in male mouse meiosis. , 2003, Developmental cell.
[21] Jan Nyman,et al. DNA double strand break quantification in skin biopsies. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[22] E. Rogakou,et al. Histone H2A variants H2AX and H2AZ. , 2002, Current opinion in genetics & development.
[23] R. Bonner,et al. Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks , 2003, Nature Cell Biology.
[24] A. Stromberg,et al. Profiling Tumor-Associated Antibodies for Early Detection of Non-small Cell Lung Cancer , 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[25] N. Carter,et al. A DNA damage checkpoint response in telomere-initiated senescence , 2003, Nature.
[26] M. Yaffe,et al. MDC1 Directly Binds Phosphorylated Histone H2AX to Regulate Cellular Responses to DNA Double-Strand Breaks , 2008, Cell.
[27] Michel C. Nussenzweig,et al. Genomic Instability in Mice Lacking Histone H2AX , 2002, Science.
[28] Y. Pommier,et al. Phosphorylation of Histone H2AX and Activation of Mre11, Rad50, and Nbs1 in Response to Replication-dependent DNA Double-strand Breaks Induced by Mammalian DNA Topoisomerase I Cleavage Complexes* , 2003, Journal of Biological Chemistry.
[29] P. Prorok,et al. Development Tracks for Cancer Prevention Markers , 2004, Disease markers.
[30] B. Zetter,et al. Cancer biomarkers: knowing the present and predicting the future. , 2005, Future oncology.
[31] M. Barbacid,et al. Tumour biology: Senescence in premalignant tumours , 2005, Nature.
[32] T. Ørntoft,et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis , 2005, Nature.
[33] B. Conley,et al. Prognostic and Predictive Markers in Cancer , 2004, Disease markers.
[34] Michael Uder,et al. In vivo formation and repair of DNA double-strand breaks after computed tomography examinations. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[35] J. Lieberman,et al. gamma-H2AX dephosphorylation by protein phosphatase 2A facilitates DNA double-strand break repair. , 2005, Molecular cell.